Rifaximin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 21 USDMF, 8 CEP/COS, 3 JDMF, 9 EU WC, 6 KDMF, 14 NDC API, 25 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 5 FDA Orange Book, 10 Europe, 1 Canada, 1 Australia, 1 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 550MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 3 DKSH, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

49 Coating Systems & Additives, 24 Controlled & Modified Release, 19 Fillers, Diluents & Binders, 16 Disintegrants & Superdisintegrants, 15 Direct Compression, 13 Thickeners and Stabilizers, 9 Film Formers & Plasticizers, 8 Co-Processed Excipients, 8 Granulation, 6 Lubricants & Glidants, 5 Empty Capsules, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Topical, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Solubilizers, 2 Rheology Modifiers, 2 Parenteral